US 6,191,126 B1Granted

Topical use of κ opioid agonists to treat ocular pain

AssigneeAlcon Laboratories, Inc.

InventorDaniel A. Gamache

Life of this patent

Estimating the term…

Abstract

The present invention relates to the pharmaceutical treatment of pain. In particular, the present invention relates to the topical use of kappa opioid receptor agonists and partial agonists for the prevention or alleviation of pain in the eye.

Claims4

Dependent claims

A method for treating ocular pain which comprises topically administering to a human eye a composition comprising a pharmaceutically effective amount of one or more kappa opioid agonist(s) in a pharmaceutically acceptable vehicle.

Dependencies are inferred from the claim text.

Facts

Application: 09/319,064Filed 27 May 1999 · us provisional application
Priority: 16 Dec 1996
Granted: 20 Feb 2001
Term ends: Not estimatedThe source records don’t support an estimate.

Classification19 codes

A61K 31/5513
Having two nitrogen atoms, e.g. dilazep: 1,4-Benzodiazepines, e.g. diazepam or clozapine
A61K 31/00
Medicinal preparations containing organic active ingredients
A61K 31/137
Having aromatic rings , e.g. ketamine, nortriptyline: arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
A61K 31/40
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having five-membered rings with one nitrogen as the only ring hetero atom,…

Family

Application60/032,909Us provisional application · filed 16 Dec 1996
US 6,191,126 B1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results